Clinical Trials · NCT05041673
Anti-diabetic Drugs and Fatty Liver Management
- Phase
- N/A
- Recruitment status
- Unknown
- Sponsor
- Alexandria University
- Enrollment
- 120
- Start date
- Feb 2021
- Locations
- 1 site, Egypt
- Primary endpoint
- Change in steatosis as measured using CAP score (fibroscan) and MRI